These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31860458)

  • 1. 30-year journey from the start of the Human Genome Project to clinical application of genomics in psychiatry: are we there yet?
    Mota NR; Franke B
    Lancet Psychiatry; 2020 Jan; 7(1):7-9. PubMed ID: 31860458
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication and physical activity and physical fitness in severe mental illness.
    Perez-Cruzado D; Cuesta-Vargas A; Vera-Garcia E; Mayoral-Cleries F
    Psychiatry Res; 2018 Sep; 267():19-24. PubMed ID: 29879601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and the Human Genome Project: implications for psychiatry.
    Kelsoe JR
    Int Rev Psychiatry; 2004 Nov; 16(4):294-300. PubMed ID: 16194762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine-Induced Fever.
    Ferreira TF; Godinho FDG; Dehanov SD; Trancas B; Maia T
    Prim Care Companion CNS Disord; 2019 Feb; 21(1):. PubMed ID: 30817864
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine associated palpebral edema: An uncommon adverse effect of a commonly prescribed drug.
    Kuppili PP; Nebhinani N; Jain S; Singhai K
    Asian J Psychiatr; 2018 Aug; 36():60-61. PubMed ID: 29966888
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomics and the future of pharmacotherapy in psychiatry.
    Malhotra AK; Lencz T; Correll CU; Kane JM
    Int Rev Psychiatry; 2007 Oct; 19(5):523-30. PubMed ID: 17896232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness study of olanzapine pamoate: Mirror-image analysis after one year].
    Potaufeu J; Langrée B; Drapier D; Burgot G; Marie N
    Encephale; 2019 Jun; 45(3):232-238. PubMed ID: 30579574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of olanzapine-induced weight gain for schizophrenia patients.
    Lin CH; Lin SC; Huang YH; Wang FC; Huang CJ
    Psychiatry Res; 2018 May; 263():207-211. PubMed ID: 29574355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
    Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
    J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
    Deng C
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No differences in olanzapine- and risperidone-related weight gain between women and men: a meta-analysis of short- and middle-term treatment.
    Schoretsanitis G; Drukker M; Van Os J; Schruers KRJ; Bak M
    Acta Psychiatr Scand; 2018 Aug; 138(2):110-122. PubMed ID: 29602172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    Dusi N; Comacchio C; Lasalvia A
    J Clin Psychopharmacol; 2019; 39(2):175-176. PubMed ID: 30640795
    [No Abstract]   [Full Text] [Related]  

  • 13. International genome project launched.
    Hayden EC
    Nature; 2008 Jan; 451(7177):378-9. PubMed ID: 18216809
    [No Abstract]   [Full Text] [Related]  

  • 14. Weight gain and longterm complications with atypical antipsychotics.
    Farver D
    S D J Med; 2001 Jan; 54(1):11-2. PubMed ID: 11211419
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute Necrotizing Pancreatitis Associated With Orally Disintegrating Formulation of Olanzapine: Implications on Clinical Presentation and Management.
    Vaidyanathan S; Subramanian K; Bharadwaj B; Das S; Kola GST; Maroju NK
    J Clin Psychopharmacol; 2019; 39(5):519-521. PubMed ID: 31433336
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomics--a global public good?
    Thorsteinsdóttir H; Daar AS; Smith RD; Singer PA
    Lancet; 2003 Mar; 361(9361):891-2. PubMed ID: 12648966
    [No Abstract]   [Full Text] [Related]  

  • 17. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
    Shah A; Suh GH
    Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589
    [No Abstract]   [Full Text] [Related]  

  • 18. The Human Genome Project and genome variation.
    Cotton RG
    Intern Med J; 2002 Jul; 32(7):285-8. PubMed ID: 12088344
    [No Abstract]   [Full Text] [Related]  

  • 19. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
    Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
    Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Third Annual Pharmacogenetics in Psychiatry Meeting, 2004.
    Hassoun Y; Razi K; Malhotra AK
    Psychiatr Genet; 2005 Sep; 15(3):155-6. PubMed ID: 16094245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.